The Impact of COVID-19 Infection in Cancer 2020–2021
Simple Summary
Introduction
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Han, G.; Sinjab, A.; Hara, K.; Treekitkarnmongkol, W.; Brennan, P.; Chang, K.; Bogatenkova, E.; Sanchez-Espiridion, B.; Behrens, C.; Solis, L.M.; et al. Single-Cell Expression Landscape of SARS-CoV-2 Receptor ACE2 and Host Proteases in Normal and Malignant Lung Tissues from Pulmonary Adenocarcinoma Patients. Cancers 2021, 13, 1250. [Google Scholar] [CrossRef] [PubMed]
- Varga, Z.; Flammer, A.J.; Steiger, P.; Haberecker, M.; Andermatt, R.; Zinkernagel, A.S. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020, 395, 1417–1418. [Google Scholar] [CrossRef] [PubMed]
- Hu, Z.-J.; Xu, J.; Yin, J.-M.; Li, L.; Hou, W.; Zhang, L.-L.; Zhou, Z.; Yu, Y.-Z.; Li, H.-J.; Feng, Y.-M.; et al. Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients. Front. Immunol. 2020, 11, 585647. [Google Scholar] [CrossRef] [PubMed]
- Zaniboni, A.; Ghidini, M.; Grossi, F.; Indini, A.; Trevisan, F.; Iaculli, A.; Dottorini, L.; Moleri, G.; Russo, A.; Vavassori, I.; et al. A Review of Clinical Practice Guidelines and Treatment Recommendations for Cancer Care in the COVID-19 Pandemic. Cancers 2020, 12, 2452. [Google Scholar] [CrossRef] [PubMed]
- Mistretta, F.A.; Luzzago, S.; Molendini, L.O.; Ferro, M.; Dossena, E.; Mastrilli, F.; Musi, G.; de Cobelli, O. A Guide for Oncologic Patient Management during Covid-19 Pandemic: The Initial Experience of an Italian Oncologic Hub with Exemplificative Focus on Uro-Oncologic Patients. Cancers 2020, 12, 1513. [Google Scholar] [CrossRef]
- Quaquarini, E.; Saltalamacchia, G.; Presti, D.; Caldana, G.; Tibollo, V.; Malovini, A.; Palumbo, R.; Emanuela Balletti, C.M.; Mollica, L.; Biscaldi, E.; et al. Impact of COVID-19 Outbreak on Cancer Patient Care and Treatment: Data from an Outpatient Oncology Clinic in Lombardy (Italy). Cancers 2020, 12, 2941. [Google Scholar] [CrossRef]
- Di Cosimo, S.; Tagliaferri, B.; Generali, D.; Giudici, F.; Agustoni, F.; Bernardo, A.; Borgonovo, K.; Farina, G.; Luchena, G.; Luciani, A.; et al. Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study. Cancers 2021, 13, 1324. [Google Scholar] [CrossRef]
- Nguyen, N.P.; Vinh-Hung, V.; Baumert, B.G.; Zamagni, A.; Arenas, M.; Motta, M.; Lara, P.C.; Myint, A.S.; Bonet, M.; Popescu, T.; et al. Older Cancer Patients during the COVID-19 Epidemic: Practice Proposal of the International Geriatric Radiotherapy Group. Cancers 2020, 12, 1287. [Google Scholar] [CrossRef]
- Quagliariello, V.; Bonelli, A.; Caronna, A.; Conforti, G.; Iovine, M.; Carbone, A.; Berretta, M.; Botti, G.; Maurea, N. SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients. Cancers 2020, 12, 3316. [Google Scholar] [CrossRef]
- Vivarelli, S.; Falzone, L.; Grillo, C.M.; Scandurra, G.; Torino, F.; Libra, M. Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial? Cancers 2020, 12, 2237. [Google Scholar] [CrossRef]
- Granier, C.; De Guillebon, E.; Blanc, C.; Roussel, H.; Badoual, C.; Colin, E.; Saldmann, A.; Gey, A.; Oudard, S.; Tartour, E.; et al. Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer. ESMO Open 2017, 2, 000213. [Google Scholar] [CrossRef] [Green Version]
- Gambichler, T.; Reuther, J.; Scheel, C.H.; Susok, L.; Kern, P.; Becker, J.C. Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection. Cancers 2020, 12, 3383. [Google Scholar] [CrossRef]
- Goshen-Lago, T.; Szwarcwort-Cohen, M.; Benguigui, M.; Almog, R.; Turgeman, I.; Zaltzman, N.; Halberthal, M.; Shaked, Y.; Ben-Aharon, I. The Potential Role of Immune Alteration in the Cancer–COVID19 Equation—A Prospective Longitudinal Study. Cancers 2020, 12, 2421. [Google Scholar] [CrossRef]
- Allegra, A.; Pioggia, G.; Tonacci, A.; Musolino, C.; Gangemi, S. Cancer and SARS-CoV-2 Infection: Diagnostic and Therapeutic Challenges. Cancers 2020, 12, 1581. [Google Scholar] [CrossRef]
- Bringel Oliveira Duarte, M.; Leal, F.; Luz Passos Argenton, J.; Barreto Campello Carvalheira, J. Outcomes of COVID-19 Patients under Cytotoxic Cancer Chemotherapy in Brazil. Cancers 2020, 12, 3490. [Google Scholar]
- Rouger-Gaudichon, J.; Thébault, E.; Félix, A.; Phulpin, A.; Paillard, C.; Alimi, A.; Brethon, B.; Gouache, E.; Raimbault, S.; de Berranger, E.; et al. Impact of the First Wave of COVID-19 on Pediatric Oncology and Hematology: A Report from the French Society of Pediatric Oncology. Cancers 2020, 12, 3398. [Google Scholar] [CrossRef]
- Duployez, N.; Demonchy, J.; Berthon, C.; Goutay, J.; Caplan, M.; Moreau, A.S.; Bignon, A.; Marceau-Renaut, A.; Garrigue, D.; Raczkiewicz, I.; et al. Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19. Cancers 2020, 12, 1992. [Google Scholar] [CrossRef]
- Singh, S.R.K.; Thanikachalam, K.; Jabbour-Aida, H.; Poisson, L.M.; Khan, G. COVID-19 and Cancer: Lessons Learnt from a Michigan Hotspot. Cancers 2020, 12, 2377. [Google Scholar] [CrossRef]
- Lee, J.; Park, S.S.; Kim, T.Y.; Lee, D.G.; Kim, D.W. Lymphopenia as a Biological Predictor of Outcomes in COVID-19 Patients: A Nationwide Cohort Study. Cancers 2021, 13, 471. [Google Scholar] [CrossRef]
- Cattrini, C.; Bersanelli, M.; Latocca, M.M.; Conte, B.; Vallome, G.; Boccardo, F. Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer. Cancers 2020, 12, 2325. [Google Scholar] [CrossRef]
- Younger, E.; Smrke, A.; Lidington, E.; Farag, S.; Ingley, K.; Chopra, N.; Maleddu, A.; Augustin, Y.; Merry, E.; Wilson, R.; et al. Health-Related Quality of Life and Experiences of Sarcoma Patients during the COVID-19 Pandemic. Cancers 2020, 12, 2288. [Google Scholar] [CrossRef] [PubMed]
- Fabi, A.; Pugliese, P.; Falbo, P.T.; Corsi, D.; Fabbri, M.A.; Vincenzi, B.; Bria, E.; Angelini, F.; Bonucci, A.; Pellegrino, A.; et al. The Experience of Oncology Healthcare Providers in the Central Italy during the COVID-19 Lockdown. Cancers 2020, 12, 3031. [Google Scholar] [CrossRef] [PubMed]
- Sadhukhan, P.; Ugurlu, M.T.; Hoque, M.O. Effect of COVID-19 on Lungs: Focusing on Prospective Malignant Phenotypes. Cancers 2020, 12, 3822. [Google Scholar] [CrossRef] [PubMed]
- Jacob, L.; Loosen, S.H.; Kalder, M.; Luedde, T.; Roderburg, C.; Kostev, K. Impact of the COVID-19 Pandemic on Cancer Diagnoses in General and Specialized Practices in Germany. Cancers 2021, 13, 408. [Google Scholar] [CrossRef] [PubMed]
- Shumilov, E.; Hoffknecht, P.; Koch, R.; Peceny, R.; Voigt, S.; Schmidt, N.; Peeck, M.; Bacher, U.; Scheithauer, S.; Trümper, L.; et al. Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers. Cancers 2021, 13, 2917. [Google Scholar] [CrossRef] [PubMed]
- Dennis, L.K.; Hsu, C.H.; Arrington, A.K. Reduction in Standard Cancer Screening in 2020 throughout the U.S. Cancers 2021, 13, 5918. [Google Scholar] [CrossRef]
- Belfiore, A.; Centonze, G.; Maisonneuve, P.; Riva, C.; Morelli, D.; Mangogna, A.; Sabella, G.; Pruneri, G.; Milione, A. COVID-19 Pandemic: Huge Stress Test for Health System Could Be a Great Opportunity to Update the Workflow in a Modern Surgical Pathology. Cancers 2021, 13, 3283. [Google Scholar] [CrossRef]
- Ruiz-Medina, S.; Gil, S.; Jimenez, B.; Rodriguez-Brazzarola, P.; Diaz-Redondo, T.; Cazorla, M.; Muñoz-Ayllon, M.; Ramos, I.; Reyna, C.; Bermejo, M.J.; et al. Significant Decrease in Annual Cancer Diagnoses in Spain during the COVID-19 Pandemic: A Real-Data Study. Cancers 2021, 13, 3215. [Google Scholar] [CrossRef]
- Tulchiner, G.; Staudacher, N.; Fritz, J.; Radmayr, C.; Culig, Z.; Horninger, W.; Pichler, R. The “COVID-19 Pandemic Gap” and Its Influence on Oncologic Outcomes of Bladder Cancer. Cancers 2021, 13, 1754. [Google Scholar] [CrossRef]
- Péron, J.; Dagonneau, T.; Conrad, A.; Pineau, F.; Calattini, S.; Freyer, G.; Perol, D.; Sajous, C.; Heiblig, M. COVID-19 Presentation and Outcomes among Cancer Patients: A Matched Case-Control Study. Cancers 2021, 13, 5283. [Google Scholar] [CrossRef]
- Benderra, M.A.; Aparicio, A.; Leblanc, J.; Wassermann, D.; Kempf, E.; Galula, G.; Bernaux, M.; Canellas, A.; Moreau, T.; Bellamine, A.; et al. Clinical Characteristics, Care Trajectories and Mortality Rate of SARS-CoV-2 Infected Cancer Patients: A Multicenter Cohort Study. Cancers 2021, 13, 4749. [Google Scholar] [CrossRef]
- Cassoni, A.; Pucci, R.; Mangini, N.; Fadda, M.T.; Battisti, A.; Giovannetti, F.; Terenzi, V.; Della Monaca, M.; Priore, P.; Raponi, I.; et al. Head and Neck Cancer Treatment during COVID-19 Pandemic: A Central Experience in Rome. Emergency Management, Infection Prevention and Control. Cancers 2021, 13, 33. [Google Scholar] [CrossRef]
- Liontos, M.; Kastritis, E.; Markellos, C.; Migkou, M.; Eleftherakis-Papaiakovou, E.; Koutsoukos, K.; Gavriatopoulou, M.; Zagouri, F.; Psaltopoulou, T.; Terpos, E.; et al. Continuing Cancer Therapy through the Pandemic While Protecting Our Patients: Results of the Implementation of Preventive Strategies in a Referral Oncology Unit. Cancers 2021, 13, 763. [Google Scholar] [CrossRef]
- Ciniselli, C.M.; Micali, A.; De Cecco, L.; Notti, P.; Sinno, V.; Luison, E.; Melani, C.C.; Daidone, M.G.; Apolone, G.; Verderio, P.; et al. SARS-CoV-2 Serology Monitoring of a Cancer Center Staff in the Pandemic Most Infected Italian Region. Cancers 2021, 13, 1035. [Google Scholar] [CrossRef]
- Mustafa, D.A.M.; Saida, L.; Latifi, D.; Wismans, L.V.; de Koning, W.; Zeneyedpour, L.; Luider, T.M.; van den Hoogen, B.; van Eijck, C.H.J. Rintatolimod Induces Antiviral Activities in Human Pancreatic Cancer Cells: Opening for an Anti-COVID-19 Opportunity in Cancer Patients? Cancers 2021, 13, 2896. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
D’Orazi, G.; Cirone, M. The Impact of COVID-19 Infection in Cancer 2020–2021. Cancers 2022, 14, 5895. https://doi.org/10.3390/cancers14235895
D’Orazi G, Cirone M. The Impact of COVID-19 Infection in Cancer 2020–2021. Cancers. 2022; 14(23):5895. https://doi.org/10.3390/cancers14235895
Chicago/Turabian StyleD’Orazi, Gabriella, and Mara Cirone. 2022. "The Impact of COVID-19 Infection in Cancer 2020–2021" Cancers 14, no. 23: 5895. https://doi.org/10.3390/cancers14235895